Axim Biotechnologies Inc (AXIM): Tear Biomarkers in Alzheimer's and Parki...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Axim Biotechnologies Inc (AXIM)

Reply Private New

Keep Last Read

Next 10 Prev Next

Send PM Follow Ignore

Followers	3
Posts	932
Boards Moderated	0
Alias Born	03/30/2021

Re: None

Thursday, 04/25/2024 6:20:21 PM

Thursday, April 25, 2024 6:20:21 PM

Tear Biomarkers in Alzheimer's and Parkinson's Diseases, and Multiple Sclerosis: Implications for Diagnosis (Systematic Review)

I just read the abstract summary of this study, but other diseases can be diagnosed through tear drops.

https://pubmed.ncbi.nlm.nih.gov/36077520/

Remember back to the video interview of CEO Mr Huemoeller by Benzinga? I think Mr Huemoeller mentioned Alzheimers.

https://finance.yahoo.com/news/video-axim-biotechnologies-ceo-presents-130000171.html

Company CEO John Huemoeller II Interviewed by Tony Noto on AXIM’s Diagnostic Research Programs in Dry Eye Disease and Parkinson’s SAN DIEGO, CA, March 27, 2024...

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent AXIM News

Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 04:59:09 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:29:50 PM
Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 09/21/2023 03:07:21 PM
Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 08/31/2023 08:10:23 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 05:35:50 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 08:11:37 PM

More AXIM News

InvestorsHub NewsWire

FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM

Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow